Source: Υπουργείο Υγείας (CY) Revision Year: 2019 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Almiral 75 mg/3 ml solution for injection or infusion.
Pharmaceutical Form |
---|
Solution for injection or infusion. Almiral is a sterile clear, colourless, or slightly yellow, solution for intramuscular injection or for preparing an intravenous infusion. |
Each ml of solution contains 25mg of diclofenac sodium.
Excipients with known effect: benzyl alcohol (52.35mg/ml), propylene glycol (0.63mg/ml), sodium metabisulphite (0.5mg/ml).
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Diclofenac |
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
List of Excipients |
---|
Benzyl alcohol |
Almiral is presented in single use amber type I glass ampoule containing 3 ml of diclofenac sodium 25 mg/ml, in packs of five, ten and one hundred ampoules.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
12858
25.07.1990 / 15.10.2013
Drug | Countries | |
---|---|---|
ALMIRAL | Cyprus, Estonia, Hong Kong, Malta, Romania, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.